Regulatory and reimbursement pathways for MedTech innovators

in partnership with MedTech Strategist

Discussants: M. W. Kayo, J. DITTMER

Summary

This session provides an in-depth exploration of regulatory and reimbursement pathways critical for MedTech innovators. It covers the transition challenges from the Medical Device Directive (MDD) to the Medical Device Regulation (MDR), sharing lessons learned and success stories. The session also addresses reimbursement frameworks in the US and Europe, offering strategic guidance for startups and scale-ups to navigate these complex landscapes effectively.

Presentations available when logged in:

  • Never give up – From MDD to MDR
  • A success story of MDR approval
  • Reimbursement from the US